Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Phio Pharmaceuticals Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Phio Pharmaceuticals Corp. Earnings Date And Information
Phio Pharmaceuticals Corp. last posted its earnings results on Monday, March 31st, 2025. The company reported $-0.85 earnings per share for the quarter, topping analysts' consensus estimates of $-1.23 by $0.38. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Phio Pharmaceuticals Corp. has generated $-1 earnings per share over the last year ($-0.91 diluted earnings per share) and currently has a price-to-earnings ratio of -10.89. Phio Pharmaceuticals Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based on prior year's report dates.
Phio Pharmaceuticals Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/15/2025 | Q1 2025 | N/A | -$0.41 | N/A | N/A | $0 |
| 03/31/2025 | Q4 2024 | -$1.23 | -$0.37 | 0.86 | $0 | $0 |
| 11/14/2024 | Q3 2024 | -$4.14 | -$1.54 | 2.6 | $0 | $0 |
| 08/14/2024 | Q2 2024 | -$4.59 | -$3.62 | 0.97 | $0 | $0 |
| 05/09/2024 | Q1 2024 | N/A | -$4.24 | N/A | N/A | $0 |
| 04/01/2024 | Q4 2023 | -$1.30 | -$4.56 | -3.26 | N/A | $30.00 K |
| 11/09/2023 | Q3 2023 | -$12.87 | -$10.26 | 2.61 | N/A | $0 |
| 08/10/2023 | Q2 2023 | N/A | -$13.29 | N/A | N/A | $0 |
| 05/11/2023 | Q1 2023 | N/A | -$28.41 | N/A | N/A | $0 |
| 03/22/2023 | Q4 2022 | -$3.24 | -$20.52 | -17.28 | $37.50 M | $0 |
| 11/10/2022 | Q3 2022 | $38.90 | -$28.33 | -67.23 | $12.50 M | $0 |
| 08/11/2022 | Q2 2022 | -$33.50 | -$20.11 | 13.39 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$32.42 | -$21.07 | 11.35 | N/A | $0 |
| 03/22/2022 | Q4 2021 | -$34.58 | -$27.57 | 7.01 | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$27.01 | -$29.89 | -2.88 | N/A | $0 |
| 08/12/2021 | Q2 2021 | -$28.09 | -$21.46 | 6.63 | N/A | $0 |
| 05/13/2021 | Q1 2021 | N/A | -$34.49 | N/A | N/A | $0 |
| 03/25/2021 | Q4 2020 | -$45.38 | -$46.05 | -0.67 | N/A | $0 |
| 11/10/2020 | Q3 2020 | -$41.06 | -$43.18 | -2.12 | N/A | $0 |
| 08/12/2020 | Q2 2020 | -$70.24 | -$36.40 | 33.84 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Phio Pharmaceuticals Corp. Earnings: FAQ's
Phio Pharmaceuticals Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based offlast year's report dates.
In the previous quarter, Phio Pharmaceuticals Corp. (:PHIO) reported $-0.85 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.23 by $0.38.
The conference call for Phio Pharmaceuticals Corp.'s latest earnings report can be listened to online.
The conference call transcript for Phio Pharmaceuticals Corp.'s latest earnings report can be read online.
Phio Pharmaceuticals Corp. (:PHIO) has a recorded net income of $-7,150,000.Phio Pharmaceuticals Corp. has generated $-0.91 earnings per share over the last four quarters.
Phio Pharmaceuticals Corp. (:PHIO) has a price-to-earnings ratio of -10.89 and price/earnings-to-growth ratio is -0.28.